Market Signal Briefing

People Inc. is first lifestyle publisher to strike an AI commercial agreement with Meta
Multi-year agreement delivers trusted content to Meta AI users from iconic People Inc. brands including PEOPLE, Better Homes & Gardens, Food & Wine, Southern Living, Allrecipes, Verywell Health, InStyle, and Investopedia
People Inc. accelerates content partner strategy across major AI platforms

, /PRNewswire/ -- People Inc., America's largest digital and print publisher, today announced a strategic content partnership with Meta as the first lifestyle publisher to make real-time content available to Meta AI users across popular categories such as entertainment, home, food, health, and finance. The deal includes celebrated People Inc. brands such as PEOPLE, Better Homes & Gardens, Allrecipes, Food & Wine, Southern Living, Verywell Health, InStyle and more. People Inc. content is expected to phase into Meta AI's experiences over the coming days.

Terms of the deal are not being publicly disclosed. The multi-year partnership provides Meta access to People Inc. content to help Meta AI users discover lifestyle topics tailored to their interests–from holiday trends to celebrity news–ensuring appropriate attribution and links back to all People Inc. websites.

"Trusted content is the lifeblood of the internet, future AI innovation depends on it," said Neil Vogel, CEO, People Inc. "We're proud to be Meta's first lifestyle content partner and to leverage our trust and scale to help people using Meta AI discover the information they need."

Continued Mr. Vogel, "Following our commercial agreements with OpenAI and Microsoft, we are accelerating our partner strategy with AI leaders who are committed to creating a thriving and sustainable internet."

About People Inc.

People Inc. is the largest digital and print publisher in America. More than 175 million people trust us each month to help them find inspiration, make decisions, and take action. People Inc.'s more than 40 iconic brands include PEOPLE, Food & Wine, Better Homes & Gardens, Verywell Health, Allrecipes, REAL SIMPLE, Investopedia, and Southern Living. People Inc. is based in New York City and is an operating business of IAC (NASDAQ: IAC).

SOURCE People Inc.

Cryogenic flow control enhances the efficacy and precision of cryoablation procedures

Robust IP portfolio becomes increasingly strategic as global interest in IceCure's  platform and next-generation cryoablation technologies grows following ProSense®'s recent FDA marketing authorization in low-risk breast cancer

, /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal, today announced it received a Notice of Allowance for a patent from the China National Intellectual Property Administration for its invention titled "Cryogen Flow Control" which relates to its next-generation XSense™ cryoablation system and probes.

A patent for this invention has been granted in Japan and is currently pending approval in the European Union, the U.S., and other major markets.

"We believe IceCure's commitment to technology innovation and our drive to make a significant impact on patient outcomes has resulted in our intellectual property portfolio in cryoablation reaching 55 patents granted and allowed across the globe," said Eyal Shamir, IceCure's Chief Executive Officer. "Our cryoablation systems and probes already have regulatory approval in China for indications including breast cancer, and we continue to innovate next-generation liquid nitrogen-based systems including XSense™ to further improve patient outcomes."

The notice of allowance for the patent addresses precise temperature control, which is crucial for efficacy and tissue safety in cryoablation procedures. Cryogenic flow control achieves this by utilizing sensor data to regulate the flow of cryogens, ensuring the desired temperature is reached and maintained at the distal tip of catheters and probes. This optimized cryogenic delivery enhances treatment effectiveness in cryoablation procedures. Advanced cryogen flow control systems may also offer functionalities, such as navigation and mapping support within the patient's anatomy, and be incorporated into a wide range of cryosurgical tools.

The ProSense® Cryoablation System is the first and only medical device to receive U.S. Food and Drug Administration ("FDA") marketing authorization for the local treatment of low-risk breast cancer with adjuvant endocrine therapy for women aged 70 and older, including patients who are not suitable for surgical alternatives for breast cancer treatment. A full list of benefits and risks can be found on the Company's website. XSense™ is the Company's next-generation cryoablation system.

About IceCure Medical

IceCure Medical (Nasdaq: ICCM) develops and markets advanced liquid-nitrogen-based cryoablation therapy systems for the destruction of tumors (benign and cancerous) by freezing, with the primary focus areas being breast, kidney, bone and lung cancer. Its minimally invasive technology is a safe and effective option to surgical tumor removal that is easily performed in a relatively short procedure. The Company's flagship ProSense® system is marketed and sold worldwide for the indications cleared and approved to date including in the U.S., Europe, and Asia.

Forward Looking Statement

This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates" and similar expressions or variations of such words are intended to identify forward-looking statements. For example, IceCure is using forward looking statements in this press release when it discusses: the pending approval of patents in the European Union, the United States and other major markets; its belief that commitment to technological innovation and its drive to make a significant impact on patient outcomes have contributed to the growth of its intellectual property portfolio; the expected benefits and performance of its next-generation XSense™ cryoablation system; its plans to continue innovating liquid nitrogen-based cryoablation technologies; the anticipated enhancement of treatment effectiveness and patient outcomes; and the potential future functionalities of cryogenic flow control systems across a wide range of cryosurgical tools. Historical results of scientific research and clinical and preclinical trials do not guarantee that the conclusions of future research or trials will suggest identical or even similar conclusions. Important factors that could cause actual results, developments and business decisions to differ materially from those anticipated in these forward-looking statements include, among others: the Company's planned level of revenues and capital expenditures; the Company's available cash and its ability to obtain additional funding; the Company's ability to market and sell its products; legal and regulatory developments in the United States and other countries; the Company's ability to maintain its relationships with suppliers, distributors and other partners; the Company's ability to maintain or protect the validity of its patents and other intellectual property; the Company's ability to expose and educate medical professionals about its products; political, economic and military instability in the Middle East, specifically in Israel; as well as those factors set forth in the Risk Factors section of the Company's Annual Report on Form 20-F for the year ended December 31, 2024 filed with the SEC on March 27, 2025, and other documents filed with or furnished to the SEC which are available on the SEC's website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

IR Contact:
Email: [email protected]
Michael Polyviou
Phone: 732-232-6914

Logo: https://mma.prnewswire.com/media/2319310/IceCure_Medical_Logo.jpg

SOURCE IceCure Medical

, /PRNewswire/ -- Sabre Corporation ("Sabre") (Nasdaq: SABR) today announced the initial results of the previously announced exchange offers (each, an "Exchange Offer" and together, the "Exchange Offers") by Sabre GLBL Inc. ("Sabre GLBL"), a wholly-owned subsidiary of Sabre, to exchange (i) any and all of its outstanding 8.625% Senior Secured Notes due 2027 (the "June 2027 Notes") and 11.250% Senior Secured Notes due 2027 (the "December 2027 Notes" and, together with the June 2027 Notes, the "2027 Notes") and (ii) up to the 2029 Notes Maximum Exchange Amount (as defined below) of its 10.750% Senior Secured Notes due 2029 (the "2029 Notes" and, together with the 2027 Notes, the "Existing Notes" and, each of them, a "series" of Existing Notes) for Sabre GLBL's new 10.750% Senior Secured Notes due 2030 (the "New Notes"), upon the terms and subject to the conditions described in the confidential offering circular, dated as of November 20, 2025, for the Exchange Offers (as it may be amended or supplemented, including by this press release, the "Offering Circular").

Sabre GLBL is also amending the Exchange Offers for each of the 2027 Notes by offering the "Early Exchange Premium" of $75 in cash in respect of all 2027 Notes that are validly tendered by 5:00 p.m., New York City time, on December 19, 2025 (such date and time, as it may be extended, the "Expiration Date"), and that are accepted for exchange, regardless of whether such 2027 Notes were tendered before or after 5:00 p.m., New York City time, on December 4, 2025 the "Early Exchange Date"). Accordingly, Eligible Holders (as defined below) who tender their 2027 Notes after the Early Exchange Date but before the Expiration Date will be eligible to receive the applicable "Total Consideration", which is $755 in cash and $320 principal amount of New Notes per $1,000 principal amount of 2027 Notes. Except for this amendment, no other terms of the Exchange Offers are being amended.

The following table sets forth the principal amount of each series of the Existing Notes that was validly tendered and not validly withdrawn as of 5:00 p.m., New York City time, on the Early Exchange Date, according to information provided by D.F. King, the information and exchange agent for the Exchange Offers (the "Exchange Agent"):

CUSIP No./ ISIN

Title of Security

Principal
Amount
Outstanding

Offering
being made

Principal Amount
Tendered by the
Early Exchange Date

Principal Amount
Expected to be Accepted
for Exchange

CUSIP: 78573NAJ1 (144A);
  U86043AG8 (Reg. S) / ISIN:
  US78573NAJ19 (144A);
  USU86043AG86 (Reg. S)..............

8.625% Senior
Secured Notes
due 2027

$331,783,000

Any and all

$235,986,000

$235,944,000

CUSIP: 78573NAH5 (144A);
  U86043AF0 (Reg. S) / ISIN:
  US78573NAH52 (144A);
  USU86043AF04 (Reg. S)...............

11.250%
Senior Secured
Notes due
2027

$45,814,000

Any and all

$44,014,000

$44,006,000

CUSIP: 78573NAL6 (144A);
  U86043AJ2 (Reg. S) / ISIN:
  US78573NAL64 (144A);
  USU86043AJ26 (Reg. S)...............

10.750%
Senior Secured
Notes due
2029

$824,714,000

Up to $379
million(1)

$676,492,000

$378,999,000

Total

$1,202,311,000

$956,492,000

$658,949,000

__________________

(1)

The maximum aggregate principal amount of New Notes that Sabre GLBL will issue in the Exchange Offer for the 2029 Notes equals to the 2029 Notes Maximum Exchange Amount as described below.

The maximum aggregate principal amount of New Notes that Sabre GLBL will issue in the Exchange Offer for the 2029 Notes equals to $379 million (as such amount may be amended by Sabre GLBL in its sole discretion, the "2029 Notes Maximum Exchange Amount"), which has been met as of the Early Exchange Date.

Sabre GLBL's obligation to accept for exchange the Existing Notes validly tendered and not validly withdrawn in each Exchange Offer is subject to the satisfaction or waiver of certain conditions as described in the Offering Circular, including the consummation of a previously announced financing.

Assuming the satisfaction or waiver by Sabre GLBL (in its sole discretion, subject to applicable law) of such conditions to the Exchange Offers, Sabre GLBL expects to pay the cash consideration and deliver the New Notes in respect of the Existing Notes validly tendered at or prior to the Early Exchange Date on December 8, 2025, unless extended (such date and time, as it may be extended, the "Early Settlement Date"), in aggregate amounts of $244.6 million in cash and $468.6 million in New Notes. Eligible Holders whose Existing Notes are accepted for exchange will be paid the accrued and unpaid interest, if any, on the Existing Notes to, but not including, the Early Settlement Date. The New Notes will be issued in minimum denominations of $2,000 and $1,000 increments thereof. Sabre GLBL will not accept tenders of Existing Notes for exchange if it would result in less than the minimum denomination of $2,000 principal amount of New Notes being issued to tendering holders.

Since the maximum aggregate principal amount of New Notes to be issued in exchange for all the tendered 2029 Notes would exceed the 2029 Notes Maximum Exchange Amount, the tendered 2029 Notes will be accepted subject to a proration factor of approximately 56.07%. Although the Exchange Offers are scheduled to expire on the Expiration Date), since 2029 Notes have been validly tendered such that the maximum aggregate principal amount of New Notes to be issued in exchange for all such tendered 2029 Notes would exceed the 2029 Notes Maximum Exchange Amount, Sabre GLBL does not expect to accept for exchange any 2029 Notes tendered after the Early Exchange Date.

Any waiver of a condition by Sabre GLBL will not constitute a waiver of any other condition. For avoidance of doubt, the Exchange Offer in respect of one series of Existing Notes is not conditioned on the Exchange Offer in respect of another series of Existing Notes, or vice versa. Sabre GLBL reserves the right to extend, amend or terminate any Exchange Offer for any reason or for no reason.

In addition, Sabre announced that Sabre GLBL will refinance certain of its existing senior secured term loans (the "Refinanced Term Loans") into two tranches in an aggregate amount of $375 million (including any premium to be paid in the form of new debt) pursuant to an amendment (the "Term Loan Refinancing Amendment") to Sabre GLBL's existing credit agreement. The Term Loan Refinancing Amendment will, among other things, extend the maturity of the Refinanced Term Loans to July 30, 2029 and modify the pricing on the Refinanced Term Loans to SOFR + CSA + 625 bps. This refinancing is expected to close on December 8, 2025, subject to customary closing conditions.

The Exchange Offers are being made only to holders of Existing Notes that have certified, by submitting an instruction to the clearing system, that they are either (i) "qualified institutional buyers" as defined in Rule 144A ("Rule 144A") under the Securities Act of 1933, as amended (the "Securities Act") or (ii) are located outside the United States and are not "U.S. persons" as defined in Rule 902 under the Securities Act (such holders, "Eligible Holders"). Only Eligible Holders are authorized to receive or review the Offering Circular or to participate in the Exchange Offers. Non-U.S. persons may also be subject to additional eligibility criteria.

BofA Securities is serving as Sole Dealer Manager for the Exchange Offers. Perella Weinberg Partners is serving as Capital Markets Advisor to Sabre.

Information Relating to the Exchange Offers

The complete terms and conditions of the Exchange Offers are set forth in the Offering Circular.  The Offering Circular contains important information and Eligible Holders are encouraged to read it in its entirety.  The Offering Circular will only be distributed to Eligible Holders who complete and return an eligibility form confirming that they are either a "qualified institutional buyer" under Rule 144A or not a "U.S. person" under Regulation S under the Securities Act for purposes of applicable securities laws.  Holders of Existing Notes who desire to complete an eligibility form should either visit www.dfking.com/sabre or request instructions by sending an e-mail to [email protected] or by calling D.F. King & Co., Inc., the information and exchange agent for the Exchange Offers, at (toll-free) (800) 578-5378 or (banks and brokers) (646) 981-1288.

None of Sabre, Sabre Holdings, Sabre GLBL, their affiliates, their respective boards of directors and stockholders, the Exchange Agent or Computershare Trust Company, N.A., as trustee for the Existing Notes and New Notes, are making any recommendation as to whether holders should tender any Existing Notes in response to the Exchange Offers. Holders must make their own decision as to whether to tender any of their Existing Notes, and, if so, the principal amount of Existing Notes to tender.

This press release is for informational purposes only and is neither an offer to buy nor a solicitation of an offer to sell any of the New Notes or any other securities. The Exchange Offers are not being made to holders of Existing Notes in any jurisdiction in which the making or acceptance thereof would not be in compliance with the securities, blue sky or other laws of such jurisdiction. The Exchange Offers are only being made pursuant to the Offering Circular. Eligible Holders are strongly encouraged to read the Offering Circular carefully because it will contain important information.

The New Notes have not been and will not be registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements.  The New Notes have not been approved or disapproved by any regulatory authority, nor has any such authority passed upon the accuracy or adequacy of the Offering Circular.

About Sabre

Sabre Corporation is a leading technology company that takes on the biggest opportunities and solves the most complex challenges in travel. Sabre harnesses speed, scale and insights to build tomorrow's technology today – empowering airlines, hoteliers, agencies and other partners to retail, distribute and fulfill travel worldwide. Headquartered in Southlake, Texas, USA, with employees across the world, Sabre serves customers in more than 160 countries globally.

Forward-Looking Statements

Statements made in this press release that are not descriptions of historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and are based on management's current expectations and assumptions and are subject to risks and uncertainties. Any statements that are not historical or current facts are forward-looking statements, including those related to the terms, timing and completion of the Exchange Offers. In many cases, you can identify forward-looking statements by terms such as "expect," "guidance," "outlook," "trend," "pro forma," "on course," "on track," "target," "potential," "benefit," "goal," "believe," "plan," "confident," "anticipate," "indicate," "trend," "position," "optimistic," "will," "forecast," "continue," "strategy," "estimate," "project," "may," "should," "would," "intend," or the negative of these terms or other comparable terminology. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Sabre's actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. The potential risks and uncertainties include, among others, our ability to realize the anticipated benefits of the Exchange Offers, the related financing and other transactions and the risk that any of the Exchange Offers or such transactions may not be consummated in the manner described herein or at all will be consummated on the terms described herein or at all. More information about potential risks and uncertainties that could affect our business and results of operations is included in the "Risk Factors" and "Forward-Looking Statements" sections in our Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on February 20, 2025, our Quarterly Report on Form 10-Q filed with the SEC on November 5, 2025, and in our other filings with the SEC. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future events, outlook, guidance, results, actions, levels of activity, performance or achievements. Readers are cautioned not to place undue reliance on these forward-looking statements. Unless required by law, we undertake no obligation to publicly update or revise any forward-looking statements to reflect circumstances or events after the date they are made.

SABR-F

Contacts:

SOURCE Sabre Corporation

Company leadership will present on December 11, 2025, at 10:00 a.m. ET and host one-on-one meetings with investors throughout both days of the conference

December 05, 2025 08:30 ET

 | Source:

LEAD REAL ESTATE CO., LTD.

TOKYO, Japan, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Lead Real Estate Co., Ltd (Nasdaq: LRE) ("LRE" or the "Company"), a Japanese real estate developer of luxury residential properties, including single-family homes and condominiums across Tokyo, Kanagawa prefecture and Sapporo, and which develops and operates the ENT TERRACE brand of extended-stay hotels, today announced that management will participate in Sidoti & Company's Year End Virtual Investor Conference, taking place December 10-11, 2025.

Eiji Nagahara, President, Chief Executive Officer, and Representative Director, and Daisuke Takahashi, Chief Financial Officer of Lead Real Estate, will deliver a corporate presentation on Thursday, December 11, 2025, at 10:00 a.m. Eastern Time. Mr. Takahashi will also be available for one-on-one virtual meetings with investors in the mornings both days of the conference.

Conference Participation Details

Event: Sidoti's Year End Virtual Investor Conference

Date: December 10-11, 2025

Presentation Date and Time: Thursday, December 11, 2025, 10:00 a.m. - 10:30 a.m. Eastern Time

Presentation Webcast Link (Public): https://sidoti.zoom.us/webinar/register/WN_y59Cj_9bR8iHQZd6Z-kNdA

One-on-One Meetings: Available throughout both days of the conference

Speakers: Mr. Eiji Nagahara, President, Chief Executive Officer, and Representative Director; Mr. Daisuke Takahashi, Chief Financial Officer

Format: Virtual

To register for the event go to https://www.meetmax.com/sched/event_127859/investor_reg_new.html?attendee_role_id=SIDOTI_INVESTOR

Investors interested in attending the presentation or scheduling a one-on-one meeting with Lead Real Estate management should contact their Sidoti representative or visit www.sidoti.com for registration information.

About Lead Real Estate Co., Ltd

Lead Real Estate Co., Ltd is a Japanese developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. In addition, the Company operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas.

The Company's mission is to serve its customers by offering stylish, safe, and luxurious living. The Company's vision is to adopt the Kaizen (continuous improvement) approach to seek to improve its operations, and to leverage its nationally recognized, award-winning luxury homes and strong market position in the luxury residential property market in Tokyo, Kanagawa prefecture, and Sapporo to create a global transaction platform allowing access to prime Japanese condominiums as well as overseas condominiums, including in the U.S. and Hong Kong.

For more information, please visit the Company's website at https://www.lead-real.co.jp/en/.

About "ENT TERRACE"

"ENT TERRACE" Series is an extended-stay hotel brand operated by Lead Real Estate Co., Ltd. ENT TERRACE provides flexible, residential-style accommodation in Tokyo's prime districts for international travelers, families and business executives seeking home-like comfort with hotel services for longer stays. ENT TERRACE GINZA PREMIUM was awarded "Luxury Apartments of the Year in Kanto" at the Travel & Hospitality Awards 2025, a renowned recognition in the international tourism industry. The Travel & Hospitality Awards celebrates the world's finest hotels and travel businesses offering remarkable experiences and service excellence. Learn more at https://ent-terrace.com/en/.

Forward-Looking Statements

Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements" within the meaning of The Private Securities Litigation Reform Act of 1995. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: the uncertainties related to market conditions and other factors that may affect its future results in the Company's registration statement and in its other filings with the U.S. Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and the Company specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events, or otherwise.

Contact Information

For Media and Investor Relations:
Daisuke Takahashi
Chief Financial Officer
Lead Real Estate Co., Ltd
[email protected]
+81 3-5784-5127

AUM Advisors
Crocker Coulson
Email: [email protected]
Tel: (646) 652-7185

Tel Aviv, Israel, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Marketplace, announced today that KeepZone AI Inc., its wholly owned subsidiary (“KeepZone” or the “Subsidiary”) has entered into a definitive distribution agreement (the “Agreement”) with Scanary Ltd. (“Scanary”), an Israeli deep-tech developer of 3D imaging, electromagnetic, AI-powered threat detection systems. This transaction marks the Company’s strategic entry into the fast-growing global homeland-security sector.

Under the Agreement, Scanary grants KeepZone the right to market and distribute Scanary’s groundbreaking AI-radar screening systems, capable of scanning up to 25,000 people per hour in open spaces without requiring them to stop. The system removes the need for traditional checkpoints and physical pat-downs, delivering seamless, real-time threat detection in under two seconds using advanced 3D imaging and AI that automatically disregards phones, keys, and other harmless objects. It is ideally suited for airports, stadiums, transit hubs, critical infrastructure, sensitive facilities, and major events – precisely the venues where demand for frictionless, high-throughput security is surging.

According to Global Market Insights report, the security scanning equipment market was valued at over $11.4 billion in 2022, with over 1 million security-scanning units dispatched, and is anticipated to grow at a CAGR of over 7% between 2023 and 2032.

Key terms of the definitive agreement include:

Exclusive distribution rights for the systems in Canada, Germany, and the United Arab Emirates for an initial 24-month period, automatically extendable for an additional 24-month period upon achieving a cumulative purchase target of 20 systems; andNon-exclusive distribution rights in Spain and Italy. Pursuant to the terms of the Agreement, in consideration for these exclusive rights, KeepZone agreed to make a one-time payment of $1 million to Scanary, payable in five equal monthly installments of $200,000, with each installment due at the end of each calendar month following the execution of the Agreement. Scanary will provide one free demonstration unit and technical support for pre-sales activities. The payment is fully repayable to KeepZone through periodic revenue payments of 10% of Scanary’s profits from sales outside the exclusive territories, in accordance with the terms of the Agreement.

About Jeffs’ Brands

Jeffs’ Brands aims to transform the world of e-commerce by creating and acquiring products and turning them into market leaders, tapping into vast, unrealized growth potential. Through the Company’s management team’s insight into the FBA Amazon business model, it aims to use both human capability and advanced technology to take products to the next level. For more information on Jeffs’ Brands visit https://jeffsbrands.com.

Forward-Looking Statement Disclaimer

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be covered by the “safe harbor” created by those sections. Forward-looking statements, which are based on certain assumptions and describe the Company’s future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as “believe,” “expect,” “may,” “should,” “could,” “seek,” “intend,” “plan,” “goal,” “estimate,” “anticipate” or other comparable terms. For example, the Company is using forward-looking statements when discussing the commercial opportunities under the Agreement and the belief that this collaboration could open new markets and growth opportunities. Instead, they are based only on the Company’s current beliefs, expectations and assumptions regarding the future of the Company’s business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of the Company’s control. The Company’s actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause the Company’s actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: the Company’s ability to adapt to significant future alterations in Amazon’s policies; the Company’s ability to sell its existing products and grow the Company’s brands and product offerings; the Company’s ability to meet its expectations regarding the revenue growth and the demand for e-commerce; the overall global economic environment; the impact of competition and new e-commerce technologies; general market, political and economic conditions in the countries in which the Company operates; projected capital expenditures and liquidity; the impact of possible changes in Amazon’s policies and terms of use; the impact of the conditions in Israel; and the other risks and uncertainties described in the Company’s Annual Report on Form 20-F for the year ended December 31, 2024, filed with the U.S. Securities and Exchange Commission (“SEC”), on March 31, 2025, and the Company’s other filings with the SEC. The Company undertakes no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Investor Relations Contact:

Michal Efraty
Adi and Michal PR- IR
Investor Relations, Israel
[email protected]

ARLINGTON, Va.--(BUSINESS WIRE)---- $AVAV #AVAV--Milancy Harris joins AV as VP & CSO, bringing deep national security expertise to strengthen protection of people, programs, and mission.

Making its debut on 12/06/2005, smart beta exchange traded fund Invesco Water Resources ETF (PHO - Free Report) provides investors broad exposure to the Industrials ETFs category of the market.

What Are Smart Beta ETFs?Products that are based on market cap weighted indexes, which are strategies designed to reflect a specific market segment or the market as a whole, have traditionally dominated the ETF industry.

A good option for investors who believe in market efficiency, market cap weighted indexes offer a low-cost, convenient, and transparent way of replicating market returns.

There are some investors, though, who think it's possible to beat the market with great stock selection; this group likely invests in another class of funds known as smart beta, which track non-cap weighted strategies.

Based on specific fundamental characteristics, or a combination of such, these indexes attempt to pick stocks that have a better chance of risk-return performance.

Even though this space provides many choices to investors--think one of the simplest methodologies like equal-weighting and more complicated ones like fundamental and volatility/momentum based weighting--not all have been able to deliver first-rate results.

Fund Sponsor & IndexPHO is managed by Invesco, and this fund has amassed over $2.15 billion, which makes it one of the larger ETFs in the Industrials ETFs. Before fees and expenses, PHO seeks to match the performance of the NASDAQ OMX US Water Index.

The NASDAQ OMX US Water Index tracks the performance of US exchange-listed companies that create products designed to conserve and purify water for homes, businesses and industries.

Cost & Other ExpensesCost is an important factor in selecting the right ETF, and cheaper funds can significantly outperform their more expensive cousins if all other fundamentals are the same.

Operating expenses on an annual basis are 0.59% for PHO, making it on par with most peer products in the space.

The fund has a 12-month trailing dividend yield of 0.54%.

Sector Exposure and Top HoldingsWhile ETFs offer diversified exposure, which minimizes single stock risk, a deep look into a fund's holdings is a valuable exercise. And, most ETFs are very transparent products that disclose their holdings on a daily basis.

This ETF has heaviest allocation in the Industrials sector - about 56.9% of the portfolio. Utilities and Information Technology round out the top three.

Looking at individual holdings, Waters Corp (WAT) accounts for about 9.89% of total assets, followed by Ferguson Enterprises Inc (FERG) and Ecolab Inc (ECL).

The top 10 holdings account for about 60.22% of total assets under management.

Performance and RiskYear-to-date, the Invesco Water Resources ETF has added roughly 10.21% so far, and it's up approximately 0.64% over the last 12 months (as of 12/05/2025). PHO has traded between $58.13 $74.61 in this past 52-week period.

The fund has a beta of 1.05 and standard deviation of 16.36% for the trailing three-year period, which makes PHO a medium risk choice in this particular space. With about 39 holdings, it has more concentrated exposure than peers .

AlternativesInvesco Water Resources ETF is a reasonable option for investors seeking to outperform the Industrials ETFs segment of the market. However, there are other ETFs in the space which investors could consider.

Invesco S&P Global Water Index ETF (CGW) tracks S&P GLOBAL WATER INDEX and the First Trust Water ETF (FIW) tracks ISE Clean Edge Water Index. Invesco S&P Global Water Index ETF has $1 billion in assets, First Trust Water ETF has $1.94 billion. CGW has an expense ratio of 0.59% and FIW changes 0.51%.

Investors looking for cheaper and lower-risk options should consider traditional market cap weighted ETFs that aim to match the returns of the Industrials ETFs

Bottom LineTo learn more about this product and other ETFs, screen for products that match your investment objectives and read articles on latest developments in the ETF investing universe, please visit Zacks ETF Center.

Important DisclaimersFXEmpire is owned and operated by Empire Media Network LTD., Company Registration Number 514641786, registered at 7 Jabotinsky Road, Ramat Gan 5252007, Israel. The content provided on this website includes general news and publications, our personal analysis and opinions, and materials provided by third parties. This content is intended for educational and research purposes only. It does not constitute, and should not be interpreted as, a recommendation or advice to take any action, including making any investment or purchasing any product. Before making any financial decision, you should conduct your own due diligence, exercise your own discretion, and consult with competent advisors. The content on this website is not personally directed to you, and we do not take into account your individual financial situation or needs. The information contained on this website is not necessarily provided in real time, nor is it guaranteed to be accurate. Prices displayed may be provided by market makers and not by exchanges. Any trading or other financial decision you make is entirely your own responsibility, and you must not rely solely on any information provided through the website. FXEmpire does not provide any warranty regarding the accuracy, completeness, or reliability of any information contained on the website and shall bear no responsibility for any trading losses you may incur as a result of using such information. The website may include advertisements and other promotional content. FXEmpire may receive compensation from third parties in connection with such content. FXEmpire does not endorse, recommend, or assume responsibility for the use of any third-party services or websites. Empire Media Network LTD., its employees, officers, subsidiaries, and affiliates shall not be liable for any loss or damage resulting from your use of the website or reliance on the information provided herein.Risk DisclaimersThis website contains information about cryptocurrencies, contracts for difference (CFDs), and other financial instruments, as well as about brokers, exchanges, and other entities trading in such instruments. Both cryptocurrencies and CFDs are complex instruments and involve a high risk of losing money. You should carefully consider whether you understand how these instruments work and whether you can afford to take the high risk of losing your money. FX Empire encourages you to conduct your own research before making any investment decision and to avoid investing in any financial instrument unless you fully understand how it works and the risks involved.

About Ian Lyall
Ian Lyall, a seasoned journalist and editor, brings over three decades of experience to his role as Managing Editor at Proactive. Overseeing Proactive's editorial and broadcast operations across six offices on three continents, Ian is responsible for quality control, editorial policy, and content production. He directs the creation of 50,000 pieces of real-time news, feature articles, and filmed interviews annually.
Prior to Proactive, Ian helped lead the business output at the Daily... Read more

About the publisher
Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced independently by our experienced and qualified teams of news journalists.

Proactive news team spans the world’s key finance and investing hubs with bureaus and studios in London, New York, Toronto, Vancouver, Sydney and Perth.

We are experts in medium and small-cap markets, we also keep our community up to date with blue-chip companies, commodities and broader investment stories. This is content that excites and engages motivated private investors.

The team delivers news and unique insights across the market including but not confined to: biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto and emerging digital and EV technologies.

Use of technology
Proactive has always been a forward looking and enthusiastic technology adopter.

Our human content creators are equipped with many decades of valuable expertise and experience. The team also has access to and use technologies to assist and enhance workflows.

Proactive will on occasion use automation and software tools, including generative AI. Nevertheless, all content published by Proactive is edited and authored by humans, in line with best practice in regard to content production and search engine optimisation.

Netflix to acquire Warner Bros. for $72 billion in a deal that could reshape Hollywood

By

Thibault Spirlet

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email.

Netflix says the deal is worth $72 billion.

Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images

2025-12-05T12:27:04.905Z

Netflix is buying Warner Bros., adding HBO and major franchises like "Harry Potter" to its content slate.
Netflix said the deal has an equity value of $72 billion, its biggest ever acquisition.
The deal boosts Netflix's studio power, expanding its production capacity and theatrical output.

Netflix is making the biggest acquisition in its history — and one of the largest ever in entertainment — announcing Friday that it has struck a deal to acquire Warner Bros. from Warner Bros. Discovery (WBD) for an equity value of $72 billion.

The cash-and-stock deal, which has a total enterprise value of $82.7 billion, will bring together Netflix's world-dominant streaming platform with Warner Bros.' century-old studio, HBO, HBO Max, and some of the most iconic franchises in film and television—from "Harry Potter" and "Game of Thrones" to "Casablanca," "The Big Bang Theory," and the entire DC Universe.

The acquisition is expected to close after WBD spins off its Global Networks division into a separate publicly traded company, Discovery Global, a process expected to happen in the third quarter of 2026.

'Our mission has always been to entertain the world'Netflix co-CEO Ted Sarandos said the merger strengthens the company's core mission.

He called Warner Bros.' catalog "incredible" and said that bringing together classics such as "Casablanca" and "Citizen Kane" with Netflix hits like "Stranger Things," "KPop Demon Hunters," and "Squid Game" will allow the company to entertain the world "even better."

Sarandos said this merger will let Netflix give audiences "more of what they love" while helping shape the next century of global storytelling.

Netflix plans to preserve Warner Bros.' existing operations, including its theatrical release pipeline — a notable commitment at a time when traditional studios are fighting to maintain the role of theaters in a streaming-first world.

Why Netflix wants this dealWarner Bros. grants Netflix access to some of the most recognizable titles in modern entertainment, including enduring sitcoms like "Friends" and "The Big Bang Theory," as well as prestige television from HBO and cinematic landmarks such as "The Wizard of Oz" and "Casablanca."

The deal also significantly expands Netflix's production capabilities in the US and establishes the company as a more powerful theatrical pipeline.

While Netflix built its empire on original programming, it has long lacked the kind of multigenerational IP that powers its rivals, such as Disney.

If regulators approve the deal, Netflix subscribers are likely to see a much wider selection of premium content integrated directly into the platform.

Industry ImpactNetflix expects the acquisition to deliver $2-3 billion in annual cost savings by the third year and to become accretive to earnings by the second year.

The combination could fuel another wave of consolidation as legacy media companies struggle to compete with tech-backed giants that now own both distribution platforms and vast libraries of IP.

WBD shareholders will receive $23.25 in cash per share and $4.501 in Netflix stock, subject to a collar. The agreement values WBD at $27.75 per share.

Before the acquisition closes, WBD will spin off Discovery Global — a company that will house CNN, TNT Sports, Discovery Channel, Discovery+, and Bleacher Report.

Regulators are expected to scrutinize the deal closely. It still requires approval from the Department of Justice, the Federal Trade Commission, and WBD shareholders.

This is a breaking story. Please check back for updates.

Netflix

Read next

LAS VEGAS--(BUSINESS WIRE)--Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) (“Realbotix” or the “Company”), a leader in AI-powered humanoid robots, is pleased to announce the appointment of Scott Meyers as its new Chief Financial Officer, effective January 12, 2026. Scott Meyers brings extensive experience in corporate finance and public-company reporting in Canada, USA, and abroad. Scott also has experience scaling technology-focused organizations. He brings over 22 years of exp.

, /PRNewswire/ -- Intensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and development of novel intratumoral cancer therapies that are designed to kill tumors and increase immune system recognition of cancers using its proprietary non-covalent conjugation technology, today announced that it has been granted a 180 calendar day extension from The Nasdaq Stock Market LLC ("Nasdaq") to regain compliance with the Nasdaq's minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the "Rule") for continued listing on Nasdaq (the "Minimum Bid Price Requirement"), following the expiration of the initial 180 calendar day period to regain compliance on December 3, 2025, which was initially granted on June 6, 2025. The Company now has until June 1, 2026 to meet the Minimum Bid Price Requirement set forth in Nasdaq Listing Rule 5550(a)(2).

The notification has no immediate effect on the listing or trading of the Company's shares of common stock, which will continue to trade on the Nasdaq Capital Market under the symbol "INTS." To regain compliance with the Rule, the Company must maintain a closing bid price of at least $1.00 per share for a minimum of ten (10) consecutive business days on or prior to the 180-day extension period, or June 1, 2026. The Company intends to actively monitor the closing bid price of its common stock between now and the end of the extension period and intends to take all appropriate actions to cure the deficiency and regain compliance with the Rule prior to the end of the compliance period.

About Intensity Therapeutics

Intensity is a late-stage clinical biotechnology company whose novel engineered chemistry enables aqueous cytotoxic-containing drug formulations to mix and saturate a tumor's dense, high-fat, pressurized environment following direct intratumoral injection. As a result of the saturation, Intensity's clinical trials have demonstrated the ability of INT230-6 to kill tumors and elicit an adaptive immune response within days of injection, representing a new approach to cancer cell death that holds the potential to shift the treatment paradigm and turn many deadly cancers into chronic diseases even for malignancies that do not respond to conventional immunotherapy. Intensity has completed two clinical studies and enrolled over 200 patients using INT230-6; a Phase 1/2 dose escalation study in metastatic cancers including sarcomas (NCT03058289), and a Phase 2 randomized control clinical trial in locally advanced breast cancer (the "INVINCIBLE-2 Study") (NCT04781725) in women without undergoing chemotherapy prior to their surgery. The Company initiated a Phase 3 trial in soft tissue sarcoma (the "INVINCIBLE-3 Study") (NCT06263231), testing INT230-6 as second or third line monotherapy compared to the standard of care ("SOC") with overall survival as an endpoint. Intensity also initiated a Phase 2 study (the "INVINCIBLE-4 Study") (NCT06358573) in collaboration with the Swiss Cancer Group, formerly the Swiss Group for Clinical Cancer Research SAKK, as part of a Phase 2/3 program evaluating INT230-6 followed by the SOC immunochemotherapy and the SOC alone for patients with presurgical triple-negative breast cancer. Pathological complete response ("pCR") is the endpoint. For more information about Intensity, including publications, papers and posters about its novel approach to cancer therapeutics, visit www.intensitytherapeutics.com.  

About INT230-6

INT230-6, Intensity's lead proprietary investigational product candidate, is designed for direct intratumoral injection. INT230-6 was discovered using Intensity's proprietary DfuseRx℠ technology platform. The drug consists of two proven, potent anti-cancer agents, cisplatin and vinblastine sulfate, and a diffusion and cell penetration enhancer molecule ("SHAO") that facilitates the dispersion of potent cytotoxic drugs throughout tumors, allowing the active agents to diffuse into cancer cells. These agents remain in the tumor, resulting in a favorable safety profile. In addition to local disease control and direct tumor killing, INT230-6 causes a release of a bolus of neoantigens specific to the malignancy, leading to immune system engagement and systemic anti-tumor effects. Importantly, these effects are mediated without immunosuppression, which often occurs with systemic chemotherapy.

Forward-Looking Statements

Certain statements in this press release may constitute "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995, as amended to date. These statements include, but are not limited to, statements relating to the Company's expected future plans, cash runway, development activities, projected milestones, business activities or results. When or if used in this communication, the words "may," "could," "should," "anticipate," "believe," "estimate," "expect," "intend," "plan," "predict" and similar expressions and their variants, as they relate to the Company or its management, may identify forward-looking statements. The forward-looking statements contained in this press release are based on management's current expectations and projections about future events. Nevertheless, actual results or events could differ materially from the plans, intentions, and expectations disclosed in, or implied by, the forward-looking statements. These risks and uncertainties, many of which are beyond our control, include: the initiation, timing, progress and results of future preclinical studies and clinical trials and research and development programs; the need to raise additional funding before the Company can expect to generate any revenues from product sales; plans to develop and commercialize product candidates; the timing or likelihood of regulatory filings and approvals; the ability of the Company's research to generate and advance additional product candidates; the risk that product candidates that appear promising in early research and clinical trials do not demonstrate safety and/or efficacy in larger-scale or later clinical trials; the implementation of the Company's business model, strategic plans for the Company's business, product candidates and technology; commercialization, marketing and manufacturing capabilities and strategy; the rate and degree of market acceptance and clinical utility of the Company's system; the Company's competitive position; the Company's intellectual property position; developments and projections relating to the Company's competitors and its industry; the Company's ability to maintain and establish collaborations or obtain additional funding; expectations related to the use of cash and cash equivalents and investments; our potential inability to satisfy the Nasdaq Capital Market's requirements for continued listing and be subject to delisting; estimates regarding expenses, future revenue, capital requirements and needs for additional financing; and other risks described in the section entitled "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2024 and in the Company's subsequent SEC filings, which can be obtained on the SEC website at www.sec.gov. Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date on which they are made and reflect management's current estimates, projections, expectations and beliefs. The Company does not plan to update any such forward-looking statements and expressly disclaims any duty to update the information contained in this press release except as required by law.

Investor Relations Contact:
Justin Kulik
[email protected]
(516) 222-2560

Media Contact:
Matt Cossel
CORE IR
[email protected] 

SOURCE Intensity Therapeutics Inc.

Melbourne, Australia and Vancouver, Canada – TheNewswire - December 5, 2025 - Mithril Silver and Gold Limited ("Mithril” or the "Company") (TSXV: MSG) (ASX: MTH) (OTCQB: MTIRF) is pleased to announce the execution of a Purchase Option to acquire the La Dura gold-silver property close to Mithril's flagship and district scale Copalquin property, both in Durango State, Mexico. The La Dura property consists of 5 contiguous mining concessions for a total area of 2,052 hectares, located less than 5 km from the town of El Durazno and less than 20 km from the Company's flagship Copalquin District property

LOS ANGELES, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The DJS Law Group reminds investors of a class action lawsuit against aTyr Pharma, Inc. (“aTyr” or “the Company”) (NASDAQ: ATYR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Shareholders who purchased shares of ATYR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.

CLASS PERIOD: January 16, 2025 to September 12, 2025

DEADLINE: December 8, 2025

CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. aTyr was overwhelmingly positive in its statements to the market about the efficacy of its drug candidate, Efzofitimod. The Company misled investors about the drug’s potential to help patients completely taper the usage of steroids. Based on these facts, aTyr’s public statements were false and materially misleading throughout the class period.

If you are a shareholder who suffered a loss, contact us to participate.

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. There is no cost or obligation to you to participate in this case.

WHY DJS LAW GROUP? DJS Law Group’s primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.

Join the case to recover your losses.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

David J. Schwartz

DJS Law Group

274 White Plains Road, Suite 1

Eastchester, NY 10709

Phone: 914-206-9742

Email: [email protected]

December 05, 2025 07:30 ET

 | Source:

Nexxen International Ltd.

NEW YORK, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Nexxen International Ltd. (NASDAQ: NEXN) (“Nexxen” or the “Company”), a global, flexible advertising technology platform with deep expertise in data and advanced TV, today announced that members of its executive and investor relations team will participate in, and host investor meetings at, the Raymond James TMT and Consumer Conference on Tuesday, December 9, 2025, in New York, NY.

The Company will participate in a fireside chat at 8:40 AM ET on December 9, 2025. A live webcast of the session will be available in the “Events and Presentations” section of Nexxen’s investor relations website at https://investors.nexxen.com/. A replay of the webcast will be accessible following the conclusion of the live presentation for approximately one year.

For more information, or to schedule a meeting with executive management or investor relations, please contact your Raymond James representative.

About Nexxen

Nexxen empowers advertisers, agencies, publishers and broadcasters around the world to utilize data and advanced TV in the ways that are most meaningful to them. Our flexible and unified technology stack comprises a demand-side platform (“DSP”) and supply-side platform (“SSP”), with the Nexxen Data Platform at its core. With streaming in our DNA, Nexxen’s robust capabilities span discovery, planning, activation, monetization, measurement and optimization – available individually or in combination – all designed to enable our partners to achieve their goals, no matter how far-reaching or hyper niche they may be.

Nexxen is headquartered in Israel and maintains offices throughout the United States, Canada, Europe and Asia-Pacific, and is traded on Nasdaq (NEXN). For more information, visit www.nexxen.com.

For further information please contact:

Nexxen International Ltd.
Billy Eckert, Vice President of Investor Relations
[email protected]

Caroline Smith, Vice President of Communications
[email protected]

TORONTO, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Q-Gold Resources Ltd. (TSXV: QGR; OTCQB: QGLDF; Börse Frankfurt: QX9G) (“QGold” or the “Company”) is pleased to announce that it will be hosting a corporate update presentation with analysts and investors via live webinar on Wednesday, December 10, 2025, at 10:30 a.m. EST. Participants can register to attend at the following web address: https://us02web.zoom.us/meeting/register/kp-TbwUIT7-La5-KUfARow.

About Ian Lyall
Ian Lyall, a seasoned journalist and editor, brings over three decades of experience to his role as Managing Editor at Proactive. Overseeing Proactive's editorial and broadcast operations across six offices on three continents, Ian is responsible for quality control, editorial policy, and content production. He directs the creation of 50,000 pieces of real-time news, feature articles, and filmed interviews annually.
Prior to Proactive, Ian helped lead the business output at the Daily... Read more

About the publisher
Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced independently by our experienced and qualified teams of news journalists.

Proactive news team spans the world’s key finance and investing hubs with bureaus and studios in London, New York, Toronto, Vancouver, Sydney and Perth.

We are experts in medium and small-cap markets, we also keep our community up to date with blue-chip companies, commodities and broader investment stories. This is content that excites and engages motivated private investors.

The team delivers news and unique insights across the market including but not confined to: biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto and emerging digital and EV technologies.

Use of technology
Proactive has always been a forward looking and enthusiastic technology adopter.

Our human content creators are equipped with many decades of valuable expertise and experience. The team also has access to and use technologies to assist and enhance workflows.

Proactive will on occasion use automation and software tools, including generative AI. Nevertheless, all content published by Proactive is edited and authored by humans, in line with best practice in regard to content production and search engine optimisation.

HomeETFs and Funds AnalysisClosed End Funds Analysis

SummaryKayne Anderson Energy Infrastructure Fund offers stable, fee-based midstream income, insulated from volatile energy spot prices, via long-term contractual cash flows.KYN trades at an ~11% discount to NAV, boosting investor yield to 7.8% versus the underlying portfolio’s 6.95%, with monthly distributions of $0.08 per share.Leverage and NAV discount combine to enhance yield, while KYN’s payout policy prioritizes sustainability and stability over opportunistic increases.Risks include potential midstream cash flow declines, discount widening, and leverage cost increases, but KYN remains optimal for income-focused investors seeking reliable, discounted infrastructure cash flows. Pavel Kot/iStock via Getty Images

As an income investor, I am quite fond of the US energy sector because it gives me income exposure to the energy that runs the economic backbone of the wealthiest country in the world. What I

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Quick Insights

Recommended For You

Boliden AB (publ) (OTCPK:BDNNY) Discusses 2026 Operational Guidance and Outlook for Mines and Smelters December 5, 2025 3:00 AM EST

Company Participants

Olof Grenmark - Director of Investor Relations
Mikael Staffas - President & CEO
Håkan Gabrielsson - Executive VP & CFO

Conference Call Participants

Adrian Gilani Göransson - ABG Sundal Collier Holding ASA, Research Division
Krishan Agarwal - Citigroup Inc., Research Division
Liam Fitzpatrick - Deutsche Bank AG, Research Division
Marina Calero Ródenas - RBC Capital Markets, Research Division
Johannes Grunselius
Amos Fletcher - Barclays Bank PLC, Research Division
Richard Hatch - Joh. Berenberg, Gossler & Co. KG, Research Division
Christian Kopfer - Handelsbanken Capital Markets AB, Research Division
Daniel Major - UBS Investment Bank, Research Division

Presentation

Olof Grenmark
Director of Investor Relations

Ladies and gentlemen, I'd like to welcome you to this Boliden 2026 guidance presentation audiocast. My name is Olof Grenmark, and I'm Head of Investor Relations. Today, we will have a presentation led by our President and CEO, Mikael Staffas; and our CFO, Håkan Gabrielsson. We will also have a Q&A session. Mikael, welcome.

Mikael Staffas
President & CEO

Thank you, Håkan, and good morning, everybody out there. The whether here in Stockholm is actually really gloomy today, but it's not snowing like it was when we had the Q3 presentation, and we almost missed the presentation because we were stuck in traffic.

Anyway, we're going to talk about 2026 and the 2026 outlook. For the mines, well, first of all, it's the first full year with Somincor and Zinkgruvan included. So we now have them part of our -- all of our guidance initiatives. We have higher grades in the open pits, and we'll come back into more of the details around that. We also have increased milled volume in several of our mines. We have in Aitik expansion due to less diorite. In Garpenberg, we have gotten an extended permit. This permit can still be appealed, but we

Recommended For You

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share1, announced today it will report earnings results for its fourth quarter fiscal 2025 ended September 30, 2025, on Tuesday, December 16, 2025, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Tuesday, December 16, 2025 Time: 8:00 am Eastern Time To register for the conference cal.

The company was honored for the Pan-European Contact Operation and Outsourced Contact Center at the European Contact Centre and Customer Support Association's Gala

, /PRNewswire/ -- Unisys (NYSE: UIS) received two Gold Awards at the 2025 European Contact Centre and Customer Support Association (ECCCSA) Best Customer Experience Annual Awards. The company was recognized as "Best Pan European Customer Contact Operation" and "Best Outsourced Contact Center of the Year" during the ECCCSA's awards celebration.

The Unisys Digital Workplace Solutions (DWS) team was recognized for delivering personalized service and leveraging innovative technology to enhance client experiences. The team's proactive approach and commitment to excellence have empowered Unisys to maintain industry-leading standards in customer service.

"We are extremely proud of this year's ECCCSA honors, which celebrate the exceptional work of our European team in a very competitive market," said Patrycja Sobera, senior vice president and general manager, Digital Workplace Solutions, Unisys. "Every day, our dedicated team works to deliver advanced digital workplace solutions that transform and engage employees in their dynamic environments."

This is the fourth consecutive year Unisys has earned a Gold recognition from ECCCSA, and it is the first time the company's DWS business has received two Gold Awards in one year. In 2024, Unisys received Gold for "Best Customer Experience Practice."

Now in its 25th year, the ECCCSA program is Europe's longest-running and most respected customer contact awards. Winners are selected through a rigorous judging process that recognizes innovation, operational efficiency, and commitment to customer service excellence.

Visit the ECCCSA website for more information on the award program and the complete list of 2025 winners. To learn more about how Unisys can help you optimize your digital workplace, visit Digital Workplace Solutions.

About Unisys 

Unisys is a global technology solutions company that powers breakthroughs for the world's leading organizations. Our solutions – cloud, AI, digital workplace, applications and enterprise computing – help our clients challenge the status quo and unlock their full potential. To learn how we have been helping clients push what's possible for more than 150 years, visit unisys.com and follow us on LinkedIn.

RELEASE NO.: 1205/10034
Unisys and other Unisys products and services mentioned herein, as well as their respective logos, are trademarks or registered trademarks of Unisys Corporation. Any other brand or product referenced herein is acknowledged to be a trademark or registered trademark of its respective holder.
UIS-C

SOURCE Unisys Corporation

Also from this source

DALLAS , Dec. 5, 2025 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango" or the "Company") today published its Bitcoin production and mining operations update for November 2025. Bitcoin Mining Production and Mining Operations Update for November 2025 Metric November 2025 [ 1] October 2025 [ 1] Number of Bitcoin produced 546.7 602.6 Average number of Bitcoin produced per day 18.22 19.44 Total number of Bitcoin held [ 2] 6,959.3 6,412.6 Deployed hashrate 50 EH/s 50 EH/s Average operating hashrate [ 3] 44.38 EH/s 46.09 EH/s Unaudited, estimated.

December 05, 2025 6:00 AM EST | Source: Powermax Minerals Inc.
Toronto, Ontario--(Newsfile Corp. - December 5, 2025) - Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) (FWB: T23) ("Powermax" or the "Company") is pleased to announce its plans for Phase 1 exploration program for its recently optioned Pinard Project (the "Project"). The Phase 1 program has been designed to integrate historical data with new fieldwork to advance target generation and prioritize areas for follow-up exploration.

The Pinard REE Property is located in northern Ontario, Canada, roughly 70 km north-northeast of the town of Kapuskasing, and is defined by 255 contiguous mining claims spanning a total of 5178 ha. The mining claims and patents can be easily accessed via all-weather access road.

The Pinard Intrusive Complex is an alkalic to peralkalic igneous body, comprising syenitic to granitic phases consistent with other alkaline plutonic systems in the southern Archean Superior Province. Alkaline complexes of this type commonly form in extensional tectonic environments, including rift zones or deep-seated fault structures. Although the Kapuskasing Structural Zone is dominated by exhumed high-grade Archean basement, several alkaline intrusions including Pinard occur within its broader influence. Regionally, the Pinard Complex shares tectonomagmatic similarities with the nearby Clay-Howells Alkaline Complex, located approximately 20 km to the southwest, which hosts a known niobium-REE mineralized system.

Figure 1: Pinard REE Property Location Map

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/11633/277023_0b949132a4224b23_001full.jpg

The Proposed Phase 1 program at the Property will consist of the following components:

Desktop Data Compilation & GIS Modeling

Powermax plans to complete a comprehensive compilation and analysis of all available historical geological, geophysical, and geochemical datasets. These datasets would be integrated into a modern GIS-based exploration platform to refine exploration targets using advanced spatial analysis and radiometric interpretation techniques.

Field Prospecting & Geological Mapping

Systematic field prospecting and detailed geological mapping will be conducted across priority target areas to identify and characterize pegmatite zones, mineralized structures, lithological contacts, and alteration patterns.

Geochemical Sampling

The Phase 1 program will include multi-media geochemical sampling, including:

Rock sampling of outcrops and mineralized occurrencesSoil sampling across defined target gridsStream sediment sampling within key drainage catchmentsSampling results will be used to vector toward areas of potential mineralization and refine exploration targets.

Radiometric Surveys

Handheld scintillometer surveys will be conducted across target areas to detect radiometric anomalies and associated pathfinder elements in support of target delineation.

Airborne Geophysical Survey

Powermax is planning a high-resolution helicopter-borne magnetic and gamma-ray spectrometric survey over key portions of the Project area. The airborne survey is expected to assist in identifying structural trends, lithological boundaries, and radiometric anomalies associated with prospective mineralization.

"The Phase 1 program at Pinard is designed to rapidly advance our technical understanding of the Project by combining historical datasets with modern exploration techniques," said Paul Gorman, CEO of Powermax. "This systematic approach will allow us to efficiently identify and prioritize high-quality targets for follow-up work."

The Phase 1 exploration program is intended to integrate historical and newly acquired field data to generate and rank priority targets for subsequent advanced exploration programs, including trenching and potential drilling.

Qualified Person

The technical information contained in this news release has been reviewed and approved by Afzaal Pirzada, P.Geo., who is a director of the Company and a Qualified Person under National Instrument 43-101 - Standards of Disclosure for Mineral Projects.

About Powermax Minerals Inc.

Powermax Minerals Inc. is a Canadian mineral exploration company focused on advancing rare earth element projects. The Company holds an option to acquire the Cameron REE Property, comprising three mineral claims totaling approximately 2,984 hectares in British Columbia. Powermax also optioned to acquire the Atikokan REE Property, consisting of 455 unpatented mining claims in NW Ontario. Powermax also optioned to acquire the 5178 hectare Pinard REE in Northern Ontario. Powermax also owns a 100% interest in the Ogden Bear Lodge Project, in Crook County, Wyoming.

Forward-Looking Statements

This news release may contain 'forward-looking statements' within the meaning of applicable Canadian securities legislation. Forward-looking statements are based on current expectations and assumptions of management and are subject to known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied. Such statements include, but are not limited to, statements regarding potential mineralization, exploration plans, timing of activities, and future exploration results. Readers are cautioned not to place undue reliance on these forward-looking statements. Powermax Minerals Inc. disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events, or otherwise, except as required by applicable securities laws.

Neither the Canadian Securities Exchange nor its Market Regulator (as defined in CSE policies) accepts responsibility for the adequacy or accuracy of this news release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/277023

Another $113 million exited on Thursday, putting the fund on track for a sixth week in the red, its longest streak since debuting in early 2024.Updated Dec 5, 2025, 10:57 a.m. Published Dec 5, 2025, 10:53 a.m.

BlackRock’s flagship Bitcoin ETF is seeing its heaviest redemption cycle since launch, with more than $2.7 billion pulled over the past five weeks as institutional flows continue to unwind into year-end.

The iShares Bitcoin Trust (IBIT), which ballooned into a $71 billion vehicle during Bitcoin’s run to record highs, has now logged five straight weeks of outflows through Nov. 28, Bloomberg data shows.

STORY CONTINUES BELOW

Another $113 million exited on Thursday, putting the fund on track for a sixth week in the red, its longest streak since debuting in early 2024.

(SoSoValue)

The withdrawals mirror the broader shift in crypto positioning since October’s liquidation shock, when leveraged wipeouts erased over a trillion dollars in digital-asset market value and pushed Bitcoin into a confirmed bear phase.

IBIT was the largest single conduit for institutional inflows earlier this year, but that bid has reversed as fund managers cut exposure ahead of bonus season and macro uncertainty picks up.

Bitcoin has recovered to the low $92,000s this week, yet flows remain negative. Analysts say that matters more for directionality than short-term price action. Glassnode noted that the outflow cycle marks a clear break from the steady accumulation regime that underpinned BTC’s climb into October, describing the current trend as a cooling in fresh capital allocation rather than a structural exit.

Bitcoin remains down about 27% from its all-time high set in early October, and IBIT’s flow data is increasingly viewed as a proxy for broader U.S. demand.

More For You

Protocol Research: GoPlus Security

Nov 14, 2025

What to know:

As of October 2025, GoPlus has generated $4.7M in total revenue across its product lines. The GoPlus App is the primary revenue driver, contributing $2.5M (approx. 53%), followed by the SafeToken Protocol at $1.7M.GoPlus Intelligence's Token Security API averaged 717 million monthly calls year-to-date in 2025 , with a peak of nearly 1 billion calls in February 2025. Total blockchain-level requests, including transaction simulations, averaged an additional 350 million per month.Since its January 2025 launch , the $GPS token has registered over $5B in total spot volume and $10B in derivatives volume in 2025. Monthly spot volume peaked in March 2025 at over $1.1B , while derivatives volume peaked the same month at over $4B.View Full Report

More For You

Solana, XRP, ETH Extend Losses as Bitcoin’s $91K Support Back in Focus

5 hours ago

The one-month chart shows BTC still locked inside a descending structure from early November’s highs, with the latest rebound producing another lower high.

What to know:

Bitcoin remains in a volatile trading range, unable to break above $93,000, with sellers and buyers maintaining a stalemate.Ether outperformed major assets with over 5% gains, while ETF flows indicate a shift of capital from Bitcoin to Ethereum.U.S. macroeconomic data and institutional developments, such as Vanguard's crypto ETF access, are influencing market sentiment and volatility.Read full story

December 05, 2025 6:00 AM EST | Source: Happy Belly Food Group Inc.
Toronto, Ontario--(Newsfile Corp. - December 5, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands is pleased to announce the grand opening of Heal Wellness ("Heal") in Charlottetown, Prince Edward Island this Saturday, December 6th, 2025. This newest location is located at 393 University Ave., Unit 8 (Kirkwood Mews) and represents Heal's first location to open in PEI and Atlantic Canada, furthering the brand's coast-to-coast national expansion. Heal Wellness is a quick-service restaurant ("QSR") brand specializing in fresh smoothie bowls, açaí bowls, and smoothies.

Happy Belly 1

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/6625/277029_209c935d44c349d7_001full.jpg

"Heal continues to build strong momentum across Canada as we partner with experienced operators committed to the long-term growth of our brands," said Sean Black, Chief Executive Officer of Happy Belly. "This location will be operated by a seasoned multi-unit, multi-brand franchise partner whose existing Happy Belly portfolio of brands includes both Lettuce Love Café and Heal Wellness, reflecting the Company's disciplined support model of growing with strong operators across multiple concepts.

"Charlottetown is a vibrant and fast-growing community with students, families, professionals, and tourists who all value convenient, fresh, better-for-you food options. Opening our first PEI location here is a meaningful milestone as we bring Heal's energizing smoothie bowls, açaí bowls, and smoothies to Atlantic Canada."

Happy Belly 2

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/6625/277029_209c935d44c349d7_002full.jpg

Heal Wellness continues to accelerate its expansion across Canada and into the United States, solidifying its position as a leading smoothie bowl and wellness QSR brand. With 29 locations currently operating and over 168 in development, Heal contributes to a broader Happy Belly pipeline of 646 contractually committed retail franchise locations across its portfolio of emerging brands—including Heal Wellness, Rosie's Burgers, Yolks Breakfast, Via Cibo Italian Street Food, and others—at various stages of development, construction, and operation.

"We are just getting started," said Sean Black. 

About Heal Wellness
Heal Wellness was founded with a passion and mission to provide quick, fresh wellness foods that support a busy and active lifestyle. We currently offer a diverse range of smoothie bowls and smoothies. We take pride in meticulously selecting every superfood ingredient on our menu to fuel the body, including acai smoothie bowls, smoothies, and super-seed grain bowls. Our smoothie bowls are crafted with real fruit and enriched with superfoods like acai, pitaya, goji berries, chia seeds, and more.

Franchising
For franchising inquiries please see www.happybellyfg.com/franchise-with-us/ or contact us at [email protected].

About Happy Belly Food Group
Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company") is a leader in acquiring and scaling emerging food brands across Canada.

Happy Belly 3

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/6625/277029_209c935d44c349d7_003full.jpg

Sean Black
Co-founder, Chief Executive Officer

Shawn Moniz
Co-founder, Chief Operating Officer

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.

Cautionary Note Regarding Forward-Looking Statements

All statements in this press release, other than statements of historical fact, are "forward-looking information" with respect to the Company within the meaning of applicable securities laws. Forward-Looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur and include the future performance of Happy Belly and her subsidiaries. Forward-Looking statements are based on the opinions and estimates at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements. There are uncertainties inherent in forward-looking information, including factors beyond the Company's control. There are no assurances that the business plans for Happy Belly described in this news release will come into effect on the terms or time frame described herein. The Company undertakes no obligation to update forward-looking information if circumstances or management's estimates or opinions should change except as required by law. The reader is cautioned not to place undue reliance on forward-looking statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company's Management's Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedarplus.ca.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/277029